Riou et al [40] identified a subset of activated and proliferating Mtb-specific CD4+ T cells (i.e., Ki67+ HLA-DR+) as a potential marker in peripheral blood that predicts the time to sputum culture conversion in TB patients at the start of treatment. Here, MKI67 is linked to tuberculosis.